SOBO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SOBO is not a strong buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock has mixed-to-weak near-term technicals, no fresh news catalyst, and no strong proprietary buy signal. While analyst targets have trended upward and Jefferies is constructive on the SBT project, the broader analyst picture is still mixed and the recent price sits close to support rather than showing decisive upside momentum. Given the current data, the best direct call is hold, not buy.
The current price is 34.37 and the stock closed flat versus the previous close, with a slight pre-market uptick and a small regular-session decline. Technicals are not confirming an entry: MACD histogram is -0.317 and still expanding negatively, which points to weakening momentum. RSI_6 at 22.228 suggests the stock is oversold/near oversold, but the read is not enough on its own to call a clean reversal. Moving averages are converging, which usually signals indecision rather than a strong trend. Price is trading near S1 at 34.482 and above S2 at 33.857, so support is nearby, but current trend quality is weak. The next meaningful upside confirmation would be a sustained move back above the 35.495 pivot.
Jefferies recently raised its target to C$57 from C$53 and kept a Buy rating, citing earlier project start-up, lighter capex, and stronger accretion on the SOBO + Bridger + Tallgrass project. Jefferies also said commercial interest was sufficient to advance the project and expected a press release by Monday. Analyst targets from several firms have been raised over recent weeks, showing improving estimates. Options positioning is bullish, with calls dominating puts. The stock is also near technical support, which may attract value buyers.
The analyst landscape remains mixed, with several Hold/Neutral/Market Perform ratings still in place. Technically, momentum is weak, MACD is negative and worsening, and the stock has not yet reclaimed the pivot level. Hedge fund and insider activity are neutral, so there is no strong smart-money confirmation.
No usable latest-quarter financial snapshot was provided because the financial snapshot returned an error. As a result, quarterly revenue, EBITDA, cash flow, and guidance trend cannot be assessed directly from the supplied data. The only financial-related insight available is from analyst commentary referencing Q1 updates and guidance upside if market conditions hold, plus Jefferies' view that the project assumptions improved. The latest quarter season is not identifiable from the supplied financial data.
Analyst sentiment has improved recently but remains mixed. Positive changes include Jefferies raising its target to C$57 and keeping Buy, RBC lifting to C$49 with Outperform, BMO raising to C$49, TD raising to C$47, and Scotiabank nudging its target to $36. On the negative side, Goldman initiated with Sell and a $29 target, saying the valuation is too rich relative to the project timeline. Overall, targets are drifting higher, but the Wall Street view is split between constructive long-term project optimism and skepticism about timing and capital allocation. For a beginner long-term investor, the pro case is improving but not strong enough yet to justify an immediate buy.
